Pharmaceutical Powder 99% Purity Fluvoxamine Maleate CAS 61718-82-9

• Powder: Yes
• Customized: Customized
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: White Powder
• Purity: >99%
• Model NO.: Frazer-Fluvoxamine Maleate
• Appearance: White Powder
• CAS No: 61718-82-9
• Shelf Life: 2 Years
• Test Method: HPLC
• MOQ: 1kg
• Storage: Store Cool Dry Place
• Resource: Natural
• Quality Requirement: Strictly Quality Control
• Mf: C19h25f3n2o6
• MW: 434.41
• Transport Package: Foil Bag
• Specification: 99%
• Trademark: Xi′an Frazer Biotech Co., Ltd.
• Origin: China
• Production Capacity: 2000kg/Month

Product Description

Pharmaceutical Powder 99% Purity Fluvoxamine Maleate CAS 61718-82-9

 

Certification of Analysis

Item	Standard		Test Results
Identification	A.H-NMR:Comply with the structure		Complies
	B.LC-MS:Comply with the structure		Complies
	C.The IR spectrum of sample should be identical with that of reference standard;		Complies
	D.HPLC-ESI-MS The retention time of the major peak in the chromatogram of the Assay preparation corresponds to that in the chromatogram of the Standard preparation, as obtained in the Assay.		Complies
Crystallinity	meets the requirements.		Complies
Loss on drying	≤2.0%		0.19%
Heavy metals	≤10 ppm		<10ppm
Water	≤1.0%		0.1%
Sulphated ash	≤0.5%, determined on 1.0 g.		0.009%
Related substances	Unspecified impurities: for each impurity	≤0.10%	<0.10%
	Total Impurity	≤0.5%	0.18%
Purity	≥99.0%		99.7%
Assay	99.0%~101.0% (anhydrous substance).		99.8%
Microbiological Analysis
Total plate count	≤1000cfu/g		Complies
Yeast and Moulds	≤100cfu/g		Complies
E. Coli.	Absent		Negative
Salmonella	Absent		Negative
S.aureus	Absent		Negative
Storage	Preserve in well-closed, light-resistant and airtight containers.		Complies

Product Description

Fluvoxamine is an antidepressant which functions as a selective serotonin reuptake inhibitor (SSRI). Fluvoxamine was first approved by the U.S. Food and Drug Administration (FDA) in 1993 for the treatment of obsessive compulsive disorder (OCD). Fluvoxamine CR (controlled release) is approved to treat social anxiety disorder. Fluvoxamine is also prescribed to treat major depressive disorder (MDD) and anxiety disorders, such as generalized anxiety disorder (GAD), panic disorder, and post-traumatic stress disorder (PTSD).

Fluvoxamine maleate is a selective SR (serotonin reputake) inhibitor. Fluvoxamine is described to bind the human 5-HT transporter protein with high affinity (Ki = 1.6 nM) while demonstrating very low affinity at the norepinephrine transporter (Ki = 2,950 nM). Fluvoxamine maleate is a xigema Receptor agonist.

Function of Fluvoxamine Maleate

Fluvoxamine maleate tablets are suitable for the treatment of depression and related symptoms, obsessive-compulsive symptoms.
Fluvoxamine maleate tablets have a good effect on the treatment of depression, it is recommended that patients take drugs on time and in quantity.